Nawel Lalout, Mark D Wilkinson, Dagmar Wandrei, Adrian Tassoni, Antonio Atalaia, Mario Prieto, Alberto Camara, Eduardo Quemada, Mirjam Franken, Anneliene H Jonker, Georgios Paliouras, Sergiu Siminiuc, Claudio Carta, Bruna Dos Santos Vieira, Marco Roos, Rajaram Kaliyaperumal, Teresinha Evangelista, Peter A C 't Hoen, Elizabeth Vroom
{"title":"The FAIR journey of a patient-driven registry: Reflections and practical solutions from the Duchenne Data Platform FAIRification experience.","authors":"Nawel Lalout, Mark D Wilkinson, Dagmar Wandrei, Adrian Tassoni, Antonio Atalaia, Mario Prieto, Alberto Camara, Eduardo Quemada, Mirjam Franken, Anneliene H Jonker, Georgios Paliouras, Sergiu Siminiuc, Claudio Carta, Bruna Dos Santos Vieira, Marco Roos, Rajaram Kaliyaperumal, Teresinha Evangelista, Peter A C 't Hoen, Elizabeth Vroom","doi":"10.1177/22143602251382969","DOIUrl":null,"url":null,"abstract":"<p><p>BackgroundSince 2018, World Duchenne Organization, Dutch Duchenne Parent Project, and Duchenne Data Foundation have been championing efforts to make Duchenne-related data reusable in combination with data contained in other registries. Transforming human language into a coded language that machines can understand (\"FAIRification\"; FAIR, Findable, Accessible, Interoperable, Reusable) offers a solution.PurposeTo recount and reflect on the process and challenges encountered during the FAIRification of a patient-registry, the Duchenne Data Platform.MethodsThe FAIRification plan was developed by a multidisciplinary team that was coordinated by a FAIR project manager. It focused on FAIRifying common data elements for rare disease registrations and patient-related outcome data. Protecting patient privacy and autonomy were at the forefront throughout the process. FAIR data transformation was accomplished through a combination of open-source and custom-written software. Data access for federated exploration was enabled through a privacy-preserving \"data-visiting\" approach.ResultsThe plan consisted of 10 main steps and addressed social, legal, ethical, and technical issues. Proof-of-concept testing for interoperability between the Duchenne Data Platform and four other registries demonstrated that FAIR data discovery and reuse was possible. Misconceptions about FAIR data persist, which act as barriers to scaling-up community-level FAIR efforts. Suggestions for overcoming these barriers are provided.ConclusionsData visiting and federated analyses between registries is possible. Actions to help mitigate hesitation to implement FAIR in practice include seeking out existing FAIR training opportunities, addressing misconceptions as needed, contacting FAIR experts for advice and using the open-source resources that we have shared.</p>","PeriodicalId":16536,"journal":{"name":"Journal of neuromuscular diseases","volume":" ","pages":"22143602251382969"},"PeriodicalIF":3.4000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of neuromuscular diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/22143602251382969","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
BackgroundSince 2018, World Duchenne Organization, Dutch Duchenne Parent Project, and Duchenne Data Foundation have been championing efforts to make Duchenne-related data reusable in combination with data contained in other registries. Transforming human language into a coded language that machines can understand ("FAIRification"; FAIR, Findable, Accessible, Interoperable, Reusable) offers a solution.PurposeTo recount and reflect on the process and challenges encountered during the FAIRification of a patient-registry, the Duchenne Data Platform.MethodsThe FAIRification plan was developed by a multidisciplinary team that was coordinated by a FAIR project manager. It focused on FAIRifying common data elements for rare disease registrations and patient-related outcome data. Protecting patient privacy and autonomy were at the forefront throughout the process. FAIR data transformation was accomplished through a combination of open-source and custom-written software. Data access for federated exploration was enabled through a privacy-preserving "data-visiting" approach.ResultsThe plan consisted of 10 main steps and addressed social, legal, ethical, and technical issues. Proof-of-concept testing for interoperability between the Duchenne Data Platform and four other registries demonstrated that FAIR data discovery and reuse was possible. Misconceptions about FAIR data persist, which act as barriers to scaling-up community-level FAIR efforts. Suggestions for overcoming these barriers are provided.ConclusionsData visiting and federated analyses between registries is possible. Actions to help mitigate hesitation to implement FAIR in practice include seeking out existing FAIR training opportunities, addressing misconceptions as needed, contacting FAIR experts for advice and using the open-source resources that we have shared.
自2018年以来,世界杜兴组织、荷兰杜兴母项目和杜兴数据基金会一直在努力使杜兴相关数据与其他注册表中包含的数据一起可重用。将人类语言转换为机器可以理解的编码语言(“公平化”;公平,可查找,可访问,可互操作,可重用)提供了一个解决方案。目的回顾和反思杜氏数据平台(Duchenne Data Platform)患者注册系统标准化过程中遇到的挑战。方法公平化计划由一个多学科团队制定,由公平项目经理协调。它侧重于对罕见病注册和患者相关结果数据的共同数据要素进行公平化。在整个过程中,保护患者隐私和自主权是最重要的。FAIR数据转换是通过开源和定制软件的结合来完成的。联邦探索的数据访问是通过保护隐私的“数据访问”方法实现的。该计划包括10个主要步骤,涉及社会、法律、伦理和技术问题。Duchenne数据平台和其他四个注册中心之间互操作性的概念验证测试表明,FAIR数据发现和重用是可能的。对公平数据的误解仍然存在,这是扩大社区一级公平工作的障碍。提出了克服这些障碍的建议。结论注册表间的数据访问和联合分析是可行的。帮助减轻在实践中实施FAIR的犹豫的行动包括寻找现有的FAIR培训机会,根据需要解决误解,联系FAIR专家寻求建议,并使用我们共享的开源资源。
期刊介绍:
The Journal of Neuromuscular Diseases aims to facilitate progress in understanding the molecular genetics/correlates, pathogenesis, pharmacology, diagnosis and treatment of acquired and genetic neuromuscular diseases (including muscular dystrophy, myasthenia gravis, spinal muscular atrophy, neuropathies, myopathies, myotonias and myositis). The journal publishes research reports, reviews, short communications, letters-to-the-editor, and will consider research that has negative findings. The journal is dedicated to providing an open forum for original research in basic science, translational and clinical research that will improve our fundamental understanding and lead to effective treatments of neuromuscular diseases.